While T-DXd has redefined first-line survival expectations, it also demands a proactive approach to managing ILD. This clip explores the critical balance between achieving a 40-month PFS and maintaining a rigorous shared-decision making safety protocol to ensure patient outcomes remain both durable and safe.
The T-DXd Tradeoff: Balancing Breakthrough Efficacy with ILD Risk
You may also like
Recommended Videos
